We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Blood Sample Screened for Cystic Fibrosis-Causing Mutations

By LabMedica International staff writers
Posted on 31 Aug 2010
Print article
A new diagnostic test simultaneously screens a single blood sample for up to 60 cystic fibrosis-causing genetic mutations in a matter of hours.

The comprehensive and flexible cystic fibrosis (CF) test will be used to screen potential parents to determine if they are carriers of CF-causing gene mutations, and as an aid in newborn screening and confirmatory diagnostic testing in newborns and children.

The xTAG Cystic Fibrosis 60 Kit v2 detects CFTR gene mutations including the 23 CFTR gene mutations and four variants (polymorphisms) recommended by the American College of Medical Genetics (ACMG) and American College of Obstetricians and Gynecologists (ACOG); 37 additional common North American mutations, including 20 mutations that are found within Hispanic and African-American populations are also detected

Luminex Corporation (Austin, TX, USA) introduced the xTAG Cystic Fibrosis 60 Kit v2. The test recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA; Silver Spring, MD, USA).

"The launch of our new xTAG Cystic Fibrosis 60 Kit v2 is a great achievement in cystic fibrosis testing," said Patrick J. Balthrop, president and CEO of Luminex. "This cleared test has the most comprehensive genetic mutation coverage available today, featuring mutations found among Caucasians as well as those that are more commonly found in other ethnic populations. It will give doctors the ability to screen children and potential parents of many ethnicities for CF."

CF is caused by mutations in the CF transmembrane conductance regulator (CFTR) gene. To date, more than 1,500 of these mutations have been discovered. More than 10 million Americans are symptomless carriers of CF-causing gene mutations and approximately 30,000 Americans suffer from the condition. It is a common genetic disorder that causes the body to produce thick mucus that can clog the lungs and affect the digestive system.

Luminex Corporation develops, manufactures, and markets biologic testing technologies with applications throughout the diagnostic and life sciences industries.

Related Links:
American College of Medical Genetics
American College of Obstetricians and Gynecologists
Luminex Corporation
U.S. Food and Drug Administration

Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Unit-Dose Packaging solution
HLX
New
Hematocrit Centrifuge
4088M1 - Zip Compact
New
Vedolizumab ELISA
RIDASCREEN VDZ Monitoring

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The discovery of a new blood group has solved a 50- year-old mystery (Photo courtesy of 123RF)

Newly Discovered Blood Group System to Help Identify and Treat Rare Patients

The AnWj blood group antigen, a surface marker discovered in 1972, has remained a mystery regarding its genetic origin—until now. The most common cause of being AnWj-negative is linked to hematological... Read more

Microbiology

view channel
Image: The inbiome molecular culture ID technology has received FDA breakthrough device designation (Photo courtesy of inbiome)

Revolutionary Molecular Culture ID Technology to Transform Bacterial Diagnostics

Bacterial infections pose a major threat to public health, contributing to one in five deaths worldwide. Current diagnostic methods often take several days to provide results, which can delay appropriate... Read more

Pathology

view channel
Image: Confocal- & laminar flow-based detection scheme of intact virus particles, one at a time (Photo courtesy of Paz Drori)

Breakthrough Virus Detection Technology Combines Confocal Fluorescence Microscopy with Microfluidic Laminar Flow

Current virus detection often relies on polymerase chain reaction (PCR), which, while highly accurate, can be slow, labor-intensive, and requires specialized lab equipment. Antigen-based tests provide... Read more

Industry

view channel
Image: The GeneXpert system’s fast PCR Xpert tests can fight AMR and superbugs with fast and accurate PCR in one hour (Photo courtesy of Cepheid)

Cepheid Partners with Fleming Initiative to Fight Antimicrobial Resistance

Antimicrobial resistance (AMR) is responsible for over one million deaths globally each year and poses a growing challenge in treating major infectious diseases like tuberculosis, Escherichia coli (E.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.